BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32521824)

  • 1. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.
    Sang Y; Tsuji K; Inoue-Torii A; Fukushima K; Kitamura S; Wada J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaporin3A inhibitor ameliorates renal fibrosis through the regulation of JNK signaling.
    Sang Y; Tsuji K; Fukushima K; Takahashi K; Kitamura S; Wada J
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F740-F756. PubMed ID: 34747196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin3a promotes advanced diabetic nephropathy.
    Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
    Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development.
    Reidy KJ; Villegas G; Teichman J; Veron D; Shen W; Jimenez J; Thomas D; Tufro A
    Development; 2009 Dec; 136(23):3979-89. PubMed ID: 19906865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin3a signaling, podocyte shape, and glomerular disease.
    Tufro A
    Pediatr Nephrol; 2014 Apr; 29(4):751-5. PubMed ID: 24464477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A.
    Fu Y; Wang C; Zhang D; Chu X; Zhang Y; Li J
    J Cell Physiol; 2019 Nov; 234(11):20869-20878. PubMed ID: 31025335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.
    Reidy KJ; Aggarwal PK; Jimenez JJ; Thomas DB; Veron D; Tufro A
    Am J Pathol; 2013 Oct; 183(4):1156-1168. PubMed ID: 23954273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huangkui capsule alleviates doxorubicin-induced proteinuria via protecting against podocyte damage and inhibiting JAK/STAT signaling.
    Zhao L; Han S; Chai C
    J Ethnopharmacol; 2023 Apr; 306():116150. PubMed ID: 36608778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of semaphorin-3a suppresses lipopolysaccharide-induced acute kidney injury.
    Tian X; Gan H; Zeng Y; Zhao H; Tang R; Xia Y
    J Mol Med (Berl); 2018 Jul; 96(7):713-724. PubMed ID: 29909462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-content screening assay-based discovery of paullones as novel podocyte-protective agents.
    Lee HW; Arif E; Altintas MM; Quick K; Maheshwari S; Plezia A; Mahmood A; Reiser J; Nihalani D; Gupta V
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F280-F292. PubMed ID: 29046299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
    Dou C; Zhang H; Ke G; Zhang L; Lian Z; Chen X; Zhao X; Chen Y; Li R; Ma J; Li Z; Lin T; Wang W; Ye ZM; Liang X; Shi W; Zhang B; Liu S
    Clin Sci (Lond); 2020 Jun; 134(12):1305-1318. PubMed ID: 32478397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TCF7 contributes to high glucose-induced damage in human podocytes by up-regulating SEMA3A via sponging miR-16-5p.
    Jiang Z; Qian L; Yang R; Wu Y; Guo Y; Chen T
    J Diabetes Investig; 2023 Feb; 14(2):193-204. PubMed ID: 36583231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress.
    Lan X; Lederman R; Eng JM; Shoshtari SS; Saleem MA; Malhotra A; Singhal PC
    PLoS One; 2016; 11(12):e0167071. PubMed ID: 27907022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pathological retinal neovascularization by semaphorin 3A.
    Yu W; Bai Y; Han N; Wang F; Zhao M; Huang L; Li X
    Mol Vis; 2013; 19():1397-405. PubMed ID: 23825919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
    Wang J; Fu D; Senouthai S; You Y
    Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
    Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.